Glycomics Market Scope, Analysis, and Trends by 2028
Glycomics Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1.34 Billion |
Market Size by 2028 | US$ 3.22 Billion |
Global CAGR (2021 - 2028) | 13.4% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
End User-Based Insights
Based on end user, the global glycomics market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations. The pharmaceutical and biotechnology companies’ segment would hold the largest market share in 2021, and the same segment is expected to grow at the highest CAGR during the forecast period.
The glycomics market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide and meet the growing demand. Some major players contributing to the glycomics market are Merck KGaA; Agilent Technologies, Inc.; New England Biolabs; Thermo Fisher Scientific Inc.; Waters Corporation; Asparia Glycomics; Bruker Corporation; Takara Bio Inc.; S-BIO; and Shimadzu Corporation, among others.